The use of procalcitonin in patients with pyogenic liver abscesses

The results of treatment of 79 patients with pyogenic liver abscesses (AP) were analyzed. Sepsis was diagnosed in 10 (16.1%) patients. Procalcitonin (PCT) levels were used to diagnose sepsis. The duration of antibacterial therapy (ABT) was based on the determination of PCT and the patient's cli...

Full description

Saved in:
Bibliographic Details
Main Author: V. V. Novak
Format: Article
Language:English
Published: Zaporizhzhia State Medical and Pharmaceutical University 2022-03-01
Series:Сучасні медичні технології
Subjects:
Online Access:https://zmapo-journal.com/index.php/journal/article/view/176
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850034931680411648
author V. V. Novak
author_facet V. V. Novak
author_sort V. V. Novak
collection DOAJ
description The results of treatment of 79 patients with pyogenic liver abscesses (AP) were analyzed. Sepsis was diagnosed in 10 (16.1%) patients. Procalcitonin (PCT) levels were used to diagnose sepsis. The duration of antibacterial therapy (ABT) was based on the determination of PCT and the patient's clinical condition. The decision to prescribe or abstain from ABT should be reviewed within the next 6-24 hours based on the patient's clinical condition and PCT level. These values ​​should also be taken into account in the decision-making process regarding the duration of ABT, as well as the clinical course of the disease. There were no fatalities in the treatment of AP. Purpose of the study. To determine the diagnostic and prognostic significance of procalcitonin in patients with pyogenic liver abscesses. Materials and methods. The results of treatment of 79 patients with pyogenic liver abscesses were analyzed. The mean age of patients was 48.4 ± 4.7 years, with men predominating (62.9%). The inclusion criterion was the presence of pyogenic liver abscesses, the exclusion criteria were cholangiogenic and specific abscesses. The main group consisted of 44 patients who received comprehensive conservative therapy, taking into account antibacterial treatment, the duration of which was determined by determining the level of PСT. Patients in the control group (35 patients) did not differ from the main in age, sex, comorbidities, severity of the disease and the results of microbiological examination, but received conventional ABT. Results.  Carrying out adequate combined antibiotic therapy in patients with AP by determining PKT, along with surgery, reduced the recovery time of patients: 2-3 days normalization of body temperature (t = 5.66176; P <0.000001) and leukocyte formula (t = 8,56860; P <0,000001) patients of the main group compared with control patients Conclusion. Conducting ABT by determining the level of PСT contributed to a probable reduction in the length of stay in the hospital for 3 days (t = 3.95561; P = 0.000116).
format Article
id doaj-art-a7697fcc8ad24f2687fd034362f5bc28
institution DOAJ
issn 2072-9367
language English
publishDate 2022-03-01
publisher Zaporizhzhia State Medical and Pharmaceutical University
record_format Article
series Сучасні медичні технології
spelling doaj-art-a7697fcc8ad24f2687fd034362f5bc282025-08-20T02:57:40ZengZaporizhzhia State Medical and Pharmaceutical UniversityСучасні медичні технології2072-93672022-03-011(52)323510.34287/MMT.1(52).2022.6176The use of procalcitonin in patients with pyogenic liver abscessesV. V. Novak0State Institution «Zaporizhia Medical Academy of post-graduate education Ministry of Health of Ukraine», Zaporizhzhia, UkraineThe results of treatment of 79 patients with pyogenic liver abscesses (AP) were analyzed. Sepsis was diagnosed in 10 (16.1%) patients. Procalcitonin (PCT) levels were used to diagnose sepsis. The duration of antibacterial therapy (ABT) was based on the determination of PCT and the patient's clinical condition. The decision to prescribe or abstain from ABT should be reviewed within the next 6-24 hours based on the patient's clinical condition and PCT level. These values ​​should also be taken into account in the decision-making process regarding the duration of ABT, as well as the clinical course of the disease. There were no fatalities in the treatment of AP. Purpose of the study. To determine the diagnostic and prognostic significance of procalcitonin in patients with pyogenic liver abscesses. Materials and methods. The results of treatment of 79 patients with pyogenic liver abscesses were analyzed. The mean age of patients was 48.4 ± 4.7 years, with men predominating (62.9%). The inclusion criterion was the presence of pyogenic liver abscesses, the exclusion criteria were cholangiogenic and specific abscesses. The main group consisted of 44 patients who received comprehensive conservative therapy, taking into account antibacterial treatment, the duration of which was determined by determining the level of PСT. Patients in the control group (35 patients) did not differ from the main in age, sex, comorbidities, severity of the disease and the results of microbiological examination, but received conventional ABT. Results.  Carrying out adequate combined antibiotic therapy in patients with AP by determining PKT, along with surgery, reduced the recovery time of patients: 2-3 days normalization of body temperature (t = 5.66176; P <0.000001) and leukocyte formula (t = 8,56860; P <0,000001) patients of the main group compared with control patients Conclusion. Conducting ABT by determining the level of PСT contributed to a probable reduction in the length of stay in the hospital for 3 days (t = 3.95561; P = 0.000116).https://zmapo-journal.com/index.php/journal/article/view/176procalcitoninliver abscess
spellingShingle V. V. Novak
The use of procalcitonin in patients with pyogenic liver abscesses
Сучасні медичні технології
procalcitonin
liver abscess
title The use of procalcitonin in patients with pyogenic liver abscesses
title_full The use of procalcitonin in patients with pyogenic liver abscesses
title_fullStr The use of procalcitonin in patients with pyogenic liver abscesses
title_full_unstemmed The use of procalcitonin in patients with pyogenic liver abscesses
title_short The use of procalcitonin in patients with pyogenic liver abscesses
title_sort use of procalcitonin in patients with pyogenic liver abscesses
topic procalcitonin
liver abscess
url https://zmapo-journal.com/index.php/journal/article/view/176
work_keys_str_mv AT vvnovak theuseofprocalcitonininpatientswithpyogenicliverabscesses
AT vvnovak useofprocalcitonininpatientswithpyogenicliverabscesses